BioLife Solutions Reports on Shareholder Vote Matters

TL;DR

BioLife Solutions held a shareholder vote; details to follow.

AI Summary

BioLife Solutions, Inc. filed an 8-K on August 21, 2025, reporting on matters submitted to a vote of security holders as of August 20, 2025. The filing details the company's corporate actions and governance, with no specific financial transactions or material events disclosed in the provided excerpt.

Why It Matters

This filing indicates that BioLife Solutions held a vote of its security holders, which is a standard corporate governance procedure that can impact company direction and shareholder rights.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting a shareholder vote, which typically does not involve immediate financial risk or significant operational changes.

Key Players & Entities

• BioLife Solutions, Inc. (company) — Registrant
• August 20, 2025 (date) — Date of earliest event reported
• August 21, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• 94-3076866 (identifier) — IRS Employer Identification No.
• 3303 Monte Villa Parkway, Bothell, WA 98021 (address) — Principal executive offices
• ( 425 ) 402-1400 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share BLFS The Nasdaq Stock Market

Filing Documents

• blfs-20250820.htm (8-K) — 41KB
• 0000834365-25-000018.txt ( ) — 154KB
• blfs-20250820.xsd (EX-101.SCH) — 2KB
• blfs-20250820_lab.xml (EX-101.LAB) — 21KB
• blfs-20250820_pre.xml (EX-101.PRE) — 12KB
• blfs-20250820_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On August 20, 2025, BioLife Solutions, Inc. (the "Company") held its 2025 annual meeting of stockholders (the "Annual Meeting"). Only stockholders of record as of the close of business on June 23, 2025 (the "Record Date") were entitled to vote at the Annual Meeting. As of the Record Date, there were 47,835,214 shares of the Company's common stock outstanding and entitled to vote at the Annual Meeting. The number of shares of the Company's common stock present or represented by valid proxy at the Annual Meeting was 43,063,037. As addressed below, at the Annual Meeting, the Company's stockholders (i) re-elected each of Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore as directors, (ii) approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, and (iii) ratified the appointment by the audit committee of the Company's board of directors (the "Audit Committee") of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The following is a tabulation of the voting on the proposals presented at the Annual Meeting: Proposal No. 1 – Election of directors. Roderick de Greef, Catherine Coste, Amy DuRoss, Rachel Ellingson, Joydeep Goswami, Tony Hunt, and Timothy Moore were elected to serve until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disqualified from serving as a director of the Company. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Votes Roderick de Greef 39,608,298 940,390 2,514,349 Catherine Coste 40,460,424 88,264 2,514,349 Amy DuRoss 39,902,654 646,034 2,514,349 Rachel Ellingson 20,731,406 19,817,282 2,514,349 Joydeep Goswami 23,021,878 17,526,810 2,514,349 Tony Hunt

View Full Filing

View this 8-K filing on SEC EDGAR